Actuate Therapeutics Inc (ACTU) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Actuate Therapeutics Inc

    NASDAQ: ACTU · Real-Time Price · USD
    6.65
    -0.37 (-5.27%)
    At close: Sep 25, 2025, 3:59 PM
    6.66
    0.15%
    After-hours: Sep 25, 2025, 06:08 PM EDT

    Actuate Therapeutics Inc Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a
    Operating Income
    		 -25.16M -24.97M -20.21M
    Interest Income
    		 222.29K 352.67K 27.03K
    Pretax Income
    		 -27.28M -24.74M -20.16M
    Net Income
    		 -27.29M -24.74M -20.16M
    Selling & General & Admin
    		 6.48M 3.27M 3.82M
    Research & Development
    		 18.68M 21.71M 16.39M
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 25.16M 24.97M 20.21M
    Interest Expense
    		 -18.72K 43.64K 16.2K
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 25.16M 24.97M 20.21M
    Income Tax Expense
    		 800.00 n/a n/a
    Shares Outstanding (Basic)
    		 8.37M 15.03M 15.03M
    Shares Outstanding (Diluted)
    		 8.37M 15.03M 15.03M
    EPS (Basic)
    		 -3.26 -1.65 -1.34
    EPS (Diluted)
    		 -3.26 -1.65 -1.34
    EBITDA
    		 -25.16M -24.7M -20.14M
    EBIT
    		 -27.3M -24.7M -20.14M
    Depreciation & Amortization
    		 2.14M 272.85K 63.61K

    Add to Watchlist